Assessment of methods for land surface temperature retrieval from Landsat-5 TM images applicable to multiscale tree-grass ecosystem modeling

Land Surface Temperature (LST) is one of the key inputs for Soil-Vegetation-Atmosphere transfer modeling in terrestrial ecosystems. In the frame of BIOSPEC (Linking spectral information at different spatial scales with biophysical parameters of Mediterranean vegetation in the context of global change) and FLUXPEC (Monitoring changes in water and carbon fluxes from remote and proximal sensing in Mediterranean “dehesa” ecosystem) projects LST retrieved from Landsat data is required to integrate ground-based observations of energy, water, and carbon fluxes with multi-scale remotely-sensed data and assess water and carbon balance in ecologically fragile heterogeneous ecosystem of Mediterranean wooded grassland (dehesa). Thus, three methods based on the Radiative Transfer Equation were used to extract LST from a series of 2009–2011 Landsat-5 TM images to assess the applicability for temperature input generation to a Landsat-MODIS LST integration. When compared to surface temperatures simulated using MODerate resolution atmospheric TRANsmission 5 (MODTRAN 5) with atmospheric profiles inputs (LSTref), values from Single-Channel (SC) algorithm are the closest (root-mean-square deviation (RMSD) = 0.50 °C); procedure based on the online Radiative Transfer Equation Atmospheric Correction Parameters Calculator (RTE-ACPC) shows RMSD = 0.85 °C; Mono-Window algorithm (MW) presents the highest RMSD (2.34 °C) with systematical LST underestimation (bias = 1.81 °C). Differences between Landsat-retrieved LST and MODIS LST are in the range of 2 to 4 °C and can be explained mainly by differences in observation geometry, emissivity, and time mismatch between Landsat and MODIS overpasses. There is a seasonal bias in Landsat-MODIS LST differences due to greater variations in surface emissivity and thermal contrasts between landcover components

Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene.

Hypertriglyceridemia is the most frequent and limiting adverse effect of bexarotene therapy in cutaneous T-cell lymphoma (CTCL). Despite standard prophylactic measures, there is a wide variability in the severity of this complication, which could be associated with both genetic and environmental factors. To analyze the association between genetic polymorphisms of apolipoprotein genes APOA5, APOC3, and APOE and the severity of hypertriglyceridemia during bexarotene therapy and to optimize patient selection for bexarotene therapy based on adverse effect profile. This case series study was conducted in 12 university referral hospitals in Spain from September 17, 2014, to February 6, 2015. One hundred twenty-five patients with a confirmed diagnosis of CTCL who had received bexarotene therapy for at least 3 months were enrolled. Nine patients were excluded owing to missing analytic triglyceride level data, leaving a study group of 116 patients. Data on demographic and cardiovascular risk factor were collected, and a complete blood analysis, including lipid profile and genetic analysis from a saliva sample, was performed. Primary outcomes were the maximal triglyceride levels reported in association with the minor alleles of the polymorphisms studied. Among 116 patients, the mean (SD) age was 61.2 (14.7) years, 69 (59.5%) were men, and 85 (73.2%) had mycosis fungoides, the most prevalent form of CTCL. During bexarotene therapy, 96 patients (82.7%) experienced hypertriglyceridemia, which was severe or extreme in 8 of these patients (8.3%). Patients who carried minor alleles of the polymorphisms did not show significant differences in baseline triglyceride concentrations. After bexarotene treatment, carriers of at least 1 of the 2 minor alleles of APOA5 c.-1131T>C and APOC3 c.*40C>G showed lower levels of triglycerides than noncarriers (mean [SD], 241.59 [169.91] vs 330.97 [169.03] mg/dL, respectively; P = .02). These results indicate that the screening of APOA5 and APOC3 genotypes may be useful to estimate changes in triglyceride concentrations during bexarotene treatment in patients with CTCL and also to identify the best candidates for bexarotene therapy based on the expected adverse effect profile

Assessment of Methods for Land Surface Temperature Retrieval from Landsat-5 TM Images Applicable to Multiscale Tree-Grass Ecosystem Modeling

Land Surface Temperature (LST) is one of the key inputs for Soil-Vegetation-Atmosphere transfer modeling in terrestrial ecosystems. In the frame of BIOSPEC (Linking spectral information at different spatial scales with biophysical parameters of Mediterranean vegetation in the context of global change) and FLUXPEC (Monitoring changes in water and carbon fluxes from remote and proximal sensing in Mediterranean “dehesa” ecosystem) projects LST retrieved from Landsat data is required to integrate ground-based observations of energy, water, and carbon fluxes with multi-scale remotely-sensed data and assess water and carbon balance in ecologically fragile heterogeneous ecosystem of Mediterranean wooded grassland (dehesa). Thus, three methods based on the Radiative Transfer Equation were used to extract LST from a series of 2009–2011 Landsat-5 TM images to assess the applicability for temperature input generation to a Landsat-MODIS LST integration. When compared to surface temperatures simulated using MODerate resolution atmospheric TRANsmission 5 (MODTRAN 5) with atmospheric profiles inputs (LSTref), values from Single-Channel (SC) algorithm are the closest (root-mean-square deviation (RMSD) = 0.50 °C); procedure based on the online Radiative Transfer Equation Atmospheric Correction Parameters Calculator (RTE-ACPC) shows RMSD = 0.85 °C; Mono-Window algorithm (MW) presents the highest RMSD (2.34 °C) with systematical LST underestimation (bias = 1.81 °C). Differences between Landsat-retrieved LST and MODIS LST are in the range of 2 to 4 °C and can be explained mainly by differences in observation geometry, emissivity, and time mismatch between Landsat and MODIS overpasses. There is a seasonal bias in Landsat-MODIS LST differences due to greater variations in surface emissivity and thermal contrasts between landcover components

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

CatedresBackground: To estimate the prevalence and severity of menopausal symptoms and anxiety/depression and to assess the differences according to menopausal status among women living with HIV aged 45-60 years from the cohort of Spanish HIV/AIDS Research Network (CoRIS). Methods: Women were interviewed by phone between September 2017 and December 2018 to determine whether they had experienced menopausal symptoms and anxiety/depression. The Menopause Rating Scale was used to evaluate the prevalence and severity of symptoms related to menopause in three subscales: somatic, psychologic and urogenital; and the 4-item Patient Health Questionnaire was used for anxiety/depression. Logistic regression models were used to estimate odds ratios (ORs) of association between menopausal status, and other potential risk factors, the presence and severity of somatic, psychological and urogenital symptoms and of anxiety/depression. Results: Of 251 women included, 137 (54.6%) were post-, 70 (27.9%) peri- and 44 (17.5%) pre-menopausal, respectively. Median age of onset menopause was 48 years (IQR 45-50). The proportions of pre-, peri- and post-menopausal women who had experienced any menopausal symptoms were 45.5%, 60.0% and 66.4%, respectively. Both peri- and post-menopause were associated with a higher likelihood of having somatic symptoms (aOR 3.01; 95% CI 1.38-6.55 and 2.63; 1.44-4.81, respectively), while post-menopause increased the likelihood of having psychological (2.16; 1.13-4.14) and urogenital symptoms (2.54; 1.42-4.85). By other hand, post-menopausal women had a statistically significant five-fold increase in the likelihood of presenting severe urogenital symptoms than pre-menopausal women (4.90; 1.74-13.84). No significant differences by menopausal status were found for anxiety/depression. Joint/muscle problems, exhaustion and sleeping disorders were the most commonly reported symptoms among all women. Differences in the prevalences of vaginal dryness (p = 0.002), joint/muscle complaints (p = 0.032), and sweating/flush (p = 0.032) were found among the three groups. Conclusions: Women living with HIV experienced a wide variety of menopausal symptoms, some of them initiated before women had any menstrual irregularity. We found a higher likelihood of somatic symptoms in peri- and post-menopausal women, while a higher likelihood of psychological and urogenital symptoms was found in post-menopausal women. Most somatic symptoms were of low or moderate severity, probably due to the good clinical and immunological situation of these women

COVID-19 in hospitalized HIV-positive and HIV-negative patients : A matched study

CatedresObjectives: We compared the characteristics and clinical outcomes of hospitalized individuals with COVID-19 with [people with HIV (PWH)] and without (non-PWH) HIV co-infection in Spain during the first wave of the pandemic. Methods: This was a retrospective matched cohort study. People with HIV were identified by reviewing clinical records and laboratory registries of 10 922 patients in active-follow-up within the Spanish HIV Research Network (CoRIS) up to 30 June 2020. Each hospitalized PWH was matched with five non-PWH of the same age and sex randomly selected from COVID-19@Spain, a multicentre cohort of 4035 patients hospitalized with confirmed COVID-19. The main outcome was all-cause in-hospital mortality. Results: Forty-five PWH with PCR-confirmed COVID-19 were identified in CoRIS, 21 of whom were hospitalized. A total of 105 age/sex-matched controls were selected from the COVID-19@Spain cohort. The median age in both groups was 53 (Q1-Q3, 46-56) years, and 90.5% were men. In PWH, 19.1% were injecting drug users, 95.2% were on antiretroviral therapy, 94.4% had HIV-RNA < 50 copies/mL, and the median (Q1-Q3) CD4 count was 595 (349-798) cells/μL. No statistically significant differences were found between PWH and non-PWH in number of comorbidities, presenting signs and symptoms, laboratory parameters, radiology findings and severity scores on admission. Corticosteroids were administered to 33.3% and 27.4% of PWH and non-PWH, respectively (P = 0.580). Deaths during admission were documented in two (9.5%) PWH and 12 (11.4%) non-PWH (P = 0.800). Conclusions: Our findings suggest that well-controlled HIV infection does not modify the clinical presentation or worsen clinical outcomes of COVID-19 hospitalization

The Global Robotic Telescopes Intelligent Array For E-Science (GLORIA)

GLORIA is a collaborative web-2.0 project based on a network of robotic telescopes, which has become the first free-access network opened to the world for public outreach and specially for e-Science projects

Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes

Objective To compare the clinical characteristics and outcomes of patients with acute heart failure (AHF) according to clinical profiles based on congestion and perfusion determined in the emergency department (ED). Methods and results Overall, 11 261 unselected AHF patients from 41 Spanish EDs were classified according to perfusion (normoperfusion = warm; hypoperfusion = cold) and congestion (not = dry; yes = wet). Baseline and decompensation characteristics were recorded as were the main wards to which patients were admitted. The primary outcome was 1-year all-cause mortality; secondary outcomes were need for hospitalisation during the index AHF event, in-hospital all-cause mortality, prolonged hospitalisation, 7-day post-discharge ED revisit for AHF and 30-day post-discharge rehospitalisation for AHF. A total of 8558 patients (76.0%) were warm+ wet, 1929 (17.1%) cold+ wet, 675 (6.0%) warm+ dry, and 99 (0.9%) cold+ dry; hypoperfused (cold) patients were more frequently admitted to intensive care units and geriatrics departments, and warm+ wet patients were discharged home without admission. The four phenotypes differed in most of the baseline and decompensation characteristics. The 1-year mortality was 30.8%, and compared to warm+ dry, the adjusted hazard ratios were significantly increased for cold+ wet (1.660; 95% confidence interval 1.400-1.968) and cold+ dry (1.672; 95% confidence interval 1.189-2.351). Hypoperfused (cold) phenotypes also showed higher rates of index episode hospitalisation and in-hospital mortality, while congestive (wet) phenotypes had a higher risk of prolonged hospitalisation but decreased risk of rehospitalisation. No differences were observed among phenotypes in ED revisit risk. Conclusions Bedside clinical evaluation of congestion and perfusion of AHF patients upon ED arrival and classification according to phenotypic profiles proposed by the latest European Society of Cardiology guidelines provide useful complementary information and help to rapidly predict patient outcomes shortly after ED patient arrival